Colorectal Cancer Panel NRASKRASBRAF Test
Test Details
The Colorectal Cancer Panel NRASKRASBRAF Test is a genetic test that analyzes specific genes known to be associated with colorectal cancer. The panel includes three genes: NRAS, KRAS, and BRAF. These genes are commonly mutated in colorectal cancer and can activate signaling pathways that promote tumor growth.
Test Components
The test requires paraffin embedded tissue blocks as the sample condition.
Price
The cost of the Colorectal Cancer Panel NRASKRASBRAF Test is 6550.0 AED.
Report Delivery
The test results will be delivered within 7-8 days.
Method
The test is performed using Sanger Sequencing.
Test Type
The Colorectal Cancer Panel NRASKRASBRAF Test falls under the category of genetics.
Doctor
The test can be requested by a gynecologist.
Pre Test Information
The Colorectal Cancer Panel NRASKRASBRAF Test requires a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Importance of the Test
The Colorectal Cancer Panel NRASKRASBRAF Test is an important tool for the diagnosis and management of colorectal cancer. It helps identify patients who may be at increased risk for developing colorectal cancer or who may benefit from targeted therapies. The test results also assist in guiding treatment decisions and informing prognosis, allowing for more personalized and effective care.
Test Name | Colorectal Cancer Panel NRASKRASBRAF Test |
---|---|
Components | Paraffin embedded tissue blocks |
Price | 6550.0 AED |
Sample Condition | Tumor tissue |
Report Delivery | 7-8 days |
Method | Sanger Sequencing |
Test type | Genetics |
Doctor | Gynecologist |
Test Department: | |
Pre Test Information | Colorectal Cancer Panel NRAS,KRAS,BRAF] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
The Colorectal Cancer Panel is a genetic test that analyzes specific genes known to be associated with colorectal cancer. The panel includes three genes: NRAS, KRAS, and BRAF. NRAS and KRAS are oncogenes that are commonly mutated in colorectal cancer. These mutations can activate signaling pathways that promote cell growth and division, leading to the development of tumors. The BRAF gene is also frequently mutated in colorectal cancer and can activate similar pathways. By analyzing these genes, the Colorectal Cancer Panel can help identify patients who may be at increased risk for developing colorectal cancer or who may benefit from targeted therapies. The results of the test can also help guide treatment decisions and inform prognosis. Overall, the Colorectal Cancer Panel is an important tool for the diagnosis and management of colorectal cancer, allowing for more personalized and effective care. |